Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma — PRP-OSS  

Dry Eye After LASIK-Laser in Situ Keratomileusis Clinical Trial

Official title: A Prospective Interventional Non-randomized and Non-comparative Series of Cases of Patiens Suffering Ocular Surface Syndrome Post-LASIK: Outcomes After the Treatment With Platelet Rich Plasma

Status Completed

Clinical Trial Summary

To evaluate the efficacy of autologous platelet-rich plasma eye drops (E-PRP) for the treatment of chronic ocular surface syndrome (OSS) following laser in situ keratomileusis (LASIK).

Clinical Trial Description

Prospective interventional consecutive case series including 156 eyes of 80 patients affected by chronic post-LASIK OSS who were treated with autologous E-PRP 6 times a day as monotherapy for 6 weeks. Assessment after treatment with E-PRP included: dry eye symptoms, change in corrected distance visual acuity (CDVA), corneal fluorescein staining (CFS) and conjunctival hyperemia. ;

Related Conditions & MeSH terms

• Dry Eye After LASIK-Laser in Situ Keratomileusis

• NCT number: NCT03322917
• Study type: Interventional
• Source: Vissum, Instituto Oftalmológico de Alicante
• Status: Completed
• Phase: Phase 2
• Start date: July 1, 2008
• Completion date: January 17, 2013